Radicava
Total Payments
$1.5M
Transactions
6,470
Doctors
2,306
Companies
5
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $1,971 | 67 | 64 |
| 2022 | $508,005 | 70 | 28 |
| 2019 | $310,145 | 2,233 | 1,107 |
| 2018 | $458,484 | 2,475 | 1,176 |
| 2017 | $254,626 | 1,625 | 940 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $452,444 | 29 | 29.5% |
| Consulting Fee | $324,068 | 195 | 21.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $289,804 | 155 | 18.9% |
| Grant | $174,650 | 19 | 11.4% |
| Food and Beverage | $123,077 | 5,012 | 8.0% |
| Travel and Lodging | $122,583 | 407 | 8.0% |
| Honoraria | $31,155 | 10 | 2.0% |
| Education | $8,200 | 639 | 0.5% |
| Space rental or facility fees (teaching hospital only) | $7,250 | 4 | 0.5% |
Payments by Type
General
$1.1M
6,441 transactions
Research
$452,444
29 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RADICAVA (EDAVARONE) FINDINGS IN BIOMARKERS FROM ALS (REFINE-ALS) | MITSUBISHI TANABE PHARMA AMERICA, INC. | $185,942 | 0 |
| HOME-BASED SPIROMETRY THROUGH TELEMEDICINE IN AMYOTROPIC LATERAL SCLEROSIS | MITSUBISHI TANABE PHARMA AMERICA, INC. | $173,897 | 0 |
| Chicago ALS Biomarker Study | MITSUBISHI TANABE PHARMA AMERICA, INC. | $92,606 | 0 |
Top Doctors Receiving Payments for Radicava
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $634,361 | 53 |
| , MD | Clinical Neurophysiology | Saint Louis, MO | $112,022 | 200 |
| , M.D | Neuromuscular Medicine | San Antonio, TX | $80,689 | 125 |
| , M.D | Anatomic Pathology & Clinical Pathology | San Francisco, CA | $52,983 | 92 |
| , M.D | Neurology | Los Angeles, CA | $45,285 | 64 |
| , MD | Clinical Neurophysiology | Loma Linda, CA | $30,544 | 50 |
| , MD | Neurology | Tampa, FL | $27,406 | 45 |
| , MD | Neurology | Minneapolis, MN | $27,367 | 26 |
| , M.D | Neurology | Phoenix, AZ | $26,953 | 29 |
| , MD, PHD | Neuromuscular Medicine | Cleveland, OH | $26,796 | 37 |
| , MD | Neurology | Los Angeles, CA | $26,628 | 43 |
| , M.D | Neurology | Amherst, NY | $26,500 | 61 |
| , M.D | Neurology | New York, NY | $19,282 | 14 |
| , M.D | Neurology | Houston, TX | $17,401 | 27 |
| , MD | Neurology | Columbia, MO | $16,540 | 23 |
| , MD | Neurology | Boston, MA | $16,077 | 20 |
| , MD | Neurology | Cordova, TN | $15,844 | 29 |
| , MD | Neurology | Chicago, IL | $14,337 | 30 |
| , MD | Internal Medicine | Charlotte, NC | $13,657 | 65 |
| , M.D | Neurology | Lincoln, NE | $13,486 | 44 |
| , M.D.,PH.D | Neurology | Salt Lake City, UT | $12,731 | 3 |
| , MD | Neurology | Philadelphia, PA | $12,508 | 31 |
| , MD | Neurology | Jacksonville, FL | $12,467 | 17 |
| Kourosh Rezania | Neurology | Burr Ridge, IL | $11,679 | 29 |
| , MD | Neurology | Fargo, ND | $7,982 | 10 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.5M
- Total Doctors 2,306
- Transactions 6,470
About Radicava
Radicava is a drug associated with $1.5M in payments to 2,306 healthcare providers, recorded across 6,470 transactions in the CMS Open Payments database. The primary manufacturer is Mitsubishi Tanabe Pharma America, Inc..
Payment data is available from 2017 to 2023. In 2023, $1,971 was paid across 67 transactions to 64 doctors.
The most common payment nature for Radicava is "Unspecified" ($452,444, 29.5% of total).
Radicava is associated with 3 research studies, including "RADICAVA (EDAVARONE) FINDINGS IN BIOMARKERS FROM ALS (REFINE-ALS)" ($185,942).